Glucose Buddy+ for Diabetes IPA MOD (Free Paid) iOS is a comprehensive mobile application designed to help individuals manage their diabetes effectively. This user-friendly app allows users to track blood glucose levels, medication intake, and insulin doses with ease. Glucose Buddy+ features a customizable dashboard, providing quick access to vital health metrics and trends. The app supports integration with various glucose meters for automatic data syncing, reducing manual entry errors. With its meal logging capabilities, carb counting tools, and exercise tracking, Glucose Buddy+ offers a holistic approach to diabetes management. The app also includes reminder notifications for medication and doctor appointments, ensuring users stay on top of their health regimen. Whether you’re newly diagnosed or have been managing diabetes for years, Glucose Buddy+ serves as a valuable companion in maintaining optimal health and understanding your condition better. Download Glucose Buddy+ for Diabetes IPA
HomeHealth & FitnessMedicalGlucose Buddy+ for Diabetes

Glucose Buddy+ for Diabetes IPA MOD v5.430 (Free Paid) iOS
Azumio Inc.
3 November 2024 (7 months ago)
App Name | Glucose Buddy+ for Diabetes |
---|---|
Latest Version | v5.430 |
Last Updated | 3 November 2024 |
Requires | Android 12.0 |
Category | |
Size | 189.66 MB |
MOD Info | Free Paid |
1- Download Scarlet or Trollstore or Esign To install Glucose Buddy+ IPA
2- Go to settings > Profiles & devices management > trust on developer.
3- Download Glucose Buddy+ IPA on iPhone iPad And Send to Scarlet or Trollstore or Esign
1- Download Sideloadly And open for install Glucose Buddy+
2- Connect your ios device to PC. Drag the Glucose Buddy+ IPA file into Sideloadly
3- Before install Glucose Buddy+ Provide Apple ID and Password And verified It
4- Click Start To install Glucose Buddy+
5- Go to settings > Profiles & devices management > trust Glucose Buddy+ on developer.
6- And iOS 16 Go To Privacy & Security Open Developer Mode
Leave a comment
No comments. Write your first comment.
Comments are closed.